Table 3.
OPN-a | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
cancer | studies | n | category | low | medium | high | χ2 | p-value | Fisher p-value | grade |
breast | 1 | 66 | Grade 1&2 | 12 | 28 | 6 | 11.45 | 0.003263 | 0.002896 | |
Grade 3&4 | 7 | 4 | 9 | |||||||
glioma | 2 | 156 | Grade 1&2 | 21 | 13 | 11 | 8.6761 | 0.01306 | 0.01299 | |
Grade 3&4 | 28 | 31 | 52 | |||||||
lung | 1 | 35 | Grade 1&2 | 7 | 7 | 9 | 8.2031 | 1.66E-02 | 0.01238 | |
Grade 3&4 | 3 | 9 | 0 | |||||||
all | 5 | 358 | Grade 1&2 | 76 | 63 | 70 | 2.5141 | 0.2845 | 0.2836 | |
Grade 3&4 | 43 | 54 | 52 | |||||||
cancer | studies | n | category | low | medium | high | χ2 | p-value | Fisher p-value | stage |
breast | 1 | 61 | low | 17 | 16 | 19 | 15.203 | 0.0005 | 0.000369 | Stage T |
high | 0 | 9 | 0 | |||||||
breast | 1 | 58 | low | 15 | 14 | 17 | 11.696 | 0.002886 | 0.002465 | Stage N |
high | 2 | 10 | 0 | |||||||
lung | 1 | 33 | low | 5 | 5 | 6 | 0.24265 | 0.8857 | 1 | Stage |
high | 6 | 6 | 5 | |||||||
all | 2 | 134 | low | 25 | 37 | 42 | 9.4449 | 0.008894 | 0.01332 | Stage |
high | 16 | 7 | 7 |
OPN-b | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
cancer | studies | n | category | low | medium | high | χ2 | p-value | Fisher p-value | grade |
breast | 1 | 66 | Grade 1&2 | 15 | 14 | 17 | 2.7568 | 0.252 | 0.2632 | |
Grade 3&4 | 6 | 10 | 4 | |||||||
glioma | 2 | 156 | Grade 1&2 | 23 | 12 | 10 | 17.511 | 0.000158 | 0.000193 | |
Grade 3&4 | 22 | 31 | 58 | |||||||
lung | 1 | 35 | Grade 1&2 | 6 | 11 | 6 | 3.2794 | 0.194 | 0.1988 | |
Grade 3&4 | 5 | 2 | 5 | |||||||
all | 5 | 358 | Grade 1&2 | 74 | 61 | 74 | 1.2698 | 0.53 | 0.2836 | |
Grade 3&4 | 46 | 42 | 61 | |||||||
cancer | studies | n | category | low | medium | high | χ2 | p-value | Fisher p-value | stage |
breast | 1 | 61 | low | 17 | 17 | 18 | 0.66816 | 0.716 | 0.9003 | Stage T |
high | 3 | 4 | 2 | |||||||
breast | 1 | 58 | low | 14 | 16 | 16 | 0.65034 | 0.7224 | 0.7878 | Stage N |
high | 5 | 3 | 4 | |||||||
lung | 1 | 33 | low | 5 | 6 | 5 | 0.24265 | 0.8857 | 1 | Stage |
high | 6 | 5 | 6 | |||||||
all | 2 | 134 | low | 19 | 32 | 53 | 23.953 | 6.29E-06 | 1.08E-05 | Stage |
high | 19 | 6 | 5 |
OPN-c | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
cancer | studies | n | category | low | medium | high | χ2 | p-value | Fisher p-value | grade |
breast | 4 | 521 | Grade 1&2 | 121 | 88 | 83 | 8.7687 | 1.25E-02 | 1.24E-02 | |
Grade 3&4 | 69 | 71 | 89 | |||||||
glioma | 2 | 156 | Grade 1&2 | 22 | 12 | 11 | 10.655 | 0.004857 | 0.005336 | |
Grade 3&4 | 27 | 30 | 54 | |||||||
lung | 2 | 101 | Grade 1&2 | 24 | 34 | 20 | 4.1892 | 0.1231 | 0.1228 | |
Grade 3&4 | 8 | 5 | 10 | |||||||
all | 9 | 879 | Grade 1&2 | 131 | 130 | 168 | 10.77 | 0.004584 | 0.004534 | |
Grade 3&4 | 175 | 143 | 132 | |||||||
cancer | studies | n | category | low | medium | high | χ2 | p-value | Fisher p-value | stage |
breast | 3 | 577 | low | 143 | 148 | 131 | 2.6299 | 0.2685 | 0.2737 | Stage T |
high | 49 | 47 | 59 | |||||||
breast | 2 | 204 | low | 46 | 46 | 47 | 0.59581 | 0.7424 | 0.7769 | Stage N |
high | 7 | 9 | 6 | |||||||
lung | 2 | 110 | low | 12 | 36 | 10 | 13.767 | 0.001024 | 0.000944 | Stage |
high | 19 | 14 | 19 | |||||||
all | 3 | 211 | low | 29 | 37 | 73 | 29.718 | 3.52E-07 | 1.03E-07 | Stage |
high | 26 | 36 | 10 |